#ipamorelin

2 stories

Regulatory April 1, 2026 · View digest

Wellness World Eagerly Awaits FDA Peptide Reclassification

Longevity enthusiasts anticipate FDA loosening restrictions on BPC-157, ipamorelin, and MOTs-C. Industry notes it may take months for compounding pharmacies to ramp up supply after reclassification.

Regulatory March 27, 2026 · View digest

RFK Jr. Signals FDA Will Deregulate ~14 Peptides Including BPC-157 and Ipamorelin

Health Secretary Kennedy announced on Joe Rogan's podcast that the FDA will soon reclassify about 14 peptides currently restricted from compounding pharmacies, aiming to curb gray-market sourcing.